This is the first part of a two-part webinar series developed by the DCAT Supply Management Committee. Part II, Supplier Risk Management: Best Practices for Risk Mitigation during Steady-State Operations, coming Tuesday November 12, 2024.  

Webinar Overview (Part 1)

Aired Live on September 17, 2024 

Mitigating supplier risk is imperative, but how can that goal be balanced with the challenges of supplier consolidation,  industry capacity limitations, internal constraints, and other uncertainty to assure supply?   

Get a “buy-and-sell side” view on best practices and new insights on how to better assess and mitigate risk in sourcing and supplier selection and the initial make-versus- buy decision. Gain insights on:  

• Top drivers when assessing risk at a supplier; 
• Management strategies for single-sourced materials; 
• Balancing cost versus supply assurance in dual-sourcing options; 
• De-risking raw materials supply; and 
• How sustainability and other ESG (environmental, social, and governance) considerations factor in supplier risk assessment.  

Panelists & Moderator:  

Who Should Attend:

• C-suite and senior to mid-level executives of bio/pharmaceutical companies, including those with functional responsibility in sourcing, procurement, supply management and manufacturing. 
• C-suite and senior to mid-level executives of CDMOs, CMOs and suppliers, including those engaged in business development, sales, marketing and operational functions in support of bio/pharmaceutical development and manufacturing.